[Leukocyte inhibiting factor (LIF) production by human lymphocytes stimulated by bacterial lipopolysaccharides].
D000818:Animals; D000907:Antibodies, Bacterial; D000917:Antibody Formation / Q000187:drug effects; D004926:Escherichia coli / Q000276:immunology; D006736:Horses; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008263:Macrophage Migration-Inhibitory Factors / Q000096:biosynthesis*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*
D000907:Antibodies, Bacterial; D008070:Lipopolysaccharides; D008263:Macrophage Migration-Inhibitory Factors; D011135:Polysaccharides, Bacterial
Produzione di LIF (leukocyte inhibiting factor) da linfociti umani stimolati con lipopolisaccaridi batterici (LPS)